CDT Equity Inc. has announced the issuance of 224,800 shares of common stock and 3,685,815 pre-funded warrants to Corvus Capital Limited in connection with the sale of its subsidiary, Conduit Pharmaceuticals Limited. The transaction, valued at $7,000,000, was structured as a private placement and the securities were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933. The issued shares and warrants are subject to restrictions on resale and may not be offered or sold in the United States without registration or an applicable exemption. The exercise of the pre-funded warrants is subject to stockholder approval under Nasdaq rules.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CDT Equity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-027489), on December 12, 2025, and is solely responsible for the information contained therein.